At its annual shareholders meeting, Ryman Healthcare Limited announced a pivotal business reset and financial turnaround, marking a significant milestone after years of restructuring. The New Zealand and Australian aged care and retirement living operator reported its first positive free cash flow in more than 10 years during FY26, alongside notable improvements in operating profitability and substantial cost reductions. The company outlined plans to resume dividends by FY28 and introduced a refreshed strategic framework prioritizing sustainable value creation over rapid expansion.
Key Points
- Ryman Healthcare Limited (listed on ASX and NZX) is a leading aged care and retirement living provider across New Zealand and Australia, with a diverse portfolio including independent retirement communities, serviced apartments, and aged care facilities.
- In FY26, the company achieved its first positive free cash flow of $188.3 million in over a decade, with operating EBITDAF reaching $88.3 million and a loss before tax and fair value movements narrowing to -7.2 cents per share—an 87% improvement compared to FY25.
- Significant board renewal took place with new non-executive directors appointed during the review period, alongside completion of a secondary ASX listing and enhancements in governance and reporting.
- Ryman targets a FY29 cash flow increase of $150 million (up from $47 million currently) and cash release of $500 million (from $169 million), while maintaining a gearing ratio of 27.8% and over $600 million in available debt capacity, with no bank debt maturities until FY31.
- The company has shifted its strategy from rapid growth to disciplined, demand-driven development, currently with only two active construction sites, and launched a new Resident Fund product to help residents finance aged care transitions.
Demographic Drivers and Portfolio Strength Amid Growing 80+ Population
Operating across New Zealand and Australia, Ryman Healthcare is well-positioned to capitalize on demographic trends driving increased aged care demand. The company highlighted that the 80-plus population is projected to double by 2050, intensifying supply shortages in aged care services across both countries. Over 50% of Ryman’s portfolio is weighted toward aged care and serviced apartments—the segments experiencing the strongest customer demand shifts. The board noted a growing preference for higher-acuity residential aged care and assisted living, areas where Ryman has concentrated its offerings.
Regulatory changes are also underway to support aged care provision. Australia introduced a new Aged Care Act, while New Zealand’s Ministerial Advisory Group is developing funding reform recommendations ahead of the general election. These reforms aim to alleviate the growing shortage of aged care beds. Ryman’s market positioning and care-focused philosophy align with these demographic and regulatory trends, presenting growth opportunities for well-capitalized operators.
FY26 Financial Turnaround and Free Cash Flow Milestone
In FY26, Ryman Healthcare delivered a major financial turnaround, achieving its first positive free cash flow of $188.3 million in over ten years. This marked a reversal from prior capital burn and demonstrated the effectiveness of the company’s reset strategy. Operating EBITDAF rose to $88.3 million, while the loss before tax and fair value movements improved by 87% to -7.2 cents per share compared to FY25. These gains were driven by robust revenue growth and significant cost reductions through operational excellence initiatives.
The company also made strong progress toward its FY29 strategic goals, with sustainable cash flow uplift reaching $47 million toward a $150 million target and cash released totaling $169 million toward a $500 million goal. Operating EBITDAF per bed reached $17.7 thousand, advancing toward the FY29 target range of $25,000 to $30,000. The balance sheet strengthened with a gearing ratio of 27.8%, the lowest among NZX-listed New Zealand retirement village operators, and no bank debt maturities until FY31. Available debt headroom exceeds $600 million, providing financial flexibility.
Strategic Shift to Disciplined, Demand-Led Development
Ryman Healthcare has repositioned its development approach, moving away from rapid expansion toward a disciplined, demand-led model focused on sustainable value. Currently, only two sites—Patrick Hogan Village and Richard Hadlee Village—are under active construction, a significant reduction from previous levels. This strategy reduces capital intensity and exposure to construction cost inflation, which previously pressured returns. The focus is now on maximizing returns from the existing portfolio rather than growth at the expense of profitability.
The board acknowledged lessons from the intensive growth phase, identifying challenges such as a low-fee revenue model amid rising costs, excessive development relative to operational capacity, faster growth in non-village costs than resident numbers, and insufficient governance transparency. The updated value creation framework emphasizes becoming the preferred provider of care-centered living, growing recurring earnings through pricing reset and operational excellence, optimizing the existing portfolio, and pursuing value-accretive growth only through disciplined brownfield and greenfield developments in markets with confirmed demand.
Board Renewal and Governance Enhancements Supporting Business Reset
As part of its governance and strategic reset, Ryman Healthcare undertook significant board renewal. Dean Hamilton became Chair in June 2023, joined by new non-executive directors James Miller (June 2023), Kate Munnings (November 2023), David Pitman (May 2024), Scott Pritchard (November 2024), and Hamish Rumbold (May 2026). Paula Jeffs has served since November 2019. This refreshed board brings new perspectives aligned with the company’s strategic priorities.
In addition to board changes, Ryman enhanced governance and reporting transparency. The company completed a secondary ASX listing alongside its NZX listing, improving accessibility for Australian investors. Executive remuneration was restructured to align management with shareholders via long-term incentives and minimum shareholding requirements. Financial reporting improvements addressed prior governance gaps, supporting the execution of the refreshed strategy and boosting investor confidence.
First Quarter FY27 Trading Update and Occupancy Stability
Ryman’s Q1 FY27 trading update showed steady demand across segments. Retirement living resales totaled 274 units, consistent with Q1 FY26, with resale volumes stable in the 264–274 range throughout FY26 and into FY27. All regions contributed, with serviced apartments comprising a larger share of sales. New sales stock was reduced by 65 units to 414, reflecting a more conservative inventory aligned with the demand-led development strategy.
Aged care occupancy remained robust at 96.1% in Q1 FY27, unchanged from the prior quarter, indicating sustained high utilization and supporting revenue stability and operational efficiency. The combination of steady resales, improved product mix toward serviced apartments, and strong aged care occupancy suggests the portfolio reset and operational improvements are driving underlying demand momentum.
Resident Fund Product Innovation Enhances Care Transition Flexibility
During the second half of FY26, Ryman launched its Resident Fund product across New Zealand villages, enabling residents to finance aged care transitions using capital tied up in their retirement village units. This innovation offers greater flexibility and choice for residents and families moving into higher-acuity care, addressing a key market pain point. By allowing residents to leverage existing capital without external funding, the product smooths the transition process.
The Resident Fund is part of ongoing product evolution, with further developments planned for FY27. Ryman is also refining its serviced apartment offerings and expanding premium care options. These initiatives support the strategic goal of growing recurring earnings and becoming the provider of choice in care-centered living, catering to diverse resident needs throughout the aging journey.
Sustainability Advancements with Solar Farm and Emissions Reduction
Ryman Healthcare has advanced its sustainability efforts, focusing on climate action and energy independence. Its 32 GWh Ryman Healthcare Solar Farm is operational, supplying electricity equivalent to about 60% of New Zealand village consumption. This renewable energy asset lowers operational costs and carbon footprint while supporting climate commitments, representing a significant capital investment in decarbonization with long-term benefits.
The solar farm contributed to a 30% reduction in Scope 1 and 2 market-based emissions compared to FY25, marking substantial progress toward climate goals. Additionally, Ryman achieved gender pay equity and maintains balanced leadership representation with 48% female and 50% male leaders. These sustainability and diversity initiatives align with the sector’s growing emphasis on environmental stewardship and workforce inclusion, enhancing resident and staff recruitment and retention.
Strong Care Quality, Customer Satisfaction, and Brand Recognition
Ryman reported robust care quality and customer satisfaction metrics, reinforcing its care-centered repositioning. The company attained a customer Net Promoter Score of 47 across surveys of independent residents, serviced apartment residents, care residents, and relatives. Team member engagement reached 69%, reflecting strong workforce alignment and motivation—key factors for quality care and retention.
The company earned multiple accolades, including being named a Readers Digest Most Trusted Brand in New Zealand’s aged care and retirement living category and receiving six Seniors New Zealand Best Group Provider awards. A recent Culture Amp employee survey showed a 6% increase in engagement, indicating positive cultural momentum post-reset. These metrics differentiate Ryman in a competitive market and support its pricing reset by validating premium service and care quality.
Dividend Resumption Pathway and Capital Allocation Strategy
Ryman Healthcare outlined a clear capital management framework, targeting dividend resumption in FY28 after an extended capital retention period during restructuring. This reflects confidence in sustaining free cash flow improvements and the ability to fund operations while returning surplus cash to shareholders—a key milestone for equity investors.
The disciplined capital allocation approach prioritizes maintaining financial flexibility with strong liquidity, investing selectively in value-accretive developments, and returning surplus capital once strategic objectives are met. The board emphasized that portfolio growth will only proceed when returns meet investment hurdles, balancing growth, balance sheet strength, and shareholder returns over the medium term.
Strategic Priorities and Long-Term Value Creation Framework
Ryman Healthcare’s comprehensive strategic framework aims to deliver long-term value for shareholders and residents. It is founded on six pillars: recognition of strong long-term fundamentals driven by the doubling 80-plus population by 2050; portfolio positioning to capitalize on aged care and assisted living demand; clear strategic priorities enabling sustainable growth; substantial progress toward FY29 targets demonstrating execution; a reset balance sheet providing growth optionality; and a capital management framework with a defined FY28 dividend pathway.
The CEO highlighted that Ryman’s status as a care-centered living provider with capacity to grow recurring earnings through pricing resets and operational excellence positions it to capture disproportionate value from demographic and regulatory tailwinds. The strategy addresses past challenges—low pricing, excessive development, overhead growth, and governance gaps—through targeted interventions. Combining a lean operating model with high-acuity care offerings, financial discipline, and improved governance, Ryman aims to establish a sustainable earnings and cash flow profile that supports long-term shareholder value creation.